Vaxart (VXRT) Declines 36% Following Data from Phase 1 Clinical Trial Evaluating Oral COVID-19 Tablet Vaccine Candidate
- World stocks edge back, bond yields, COVID-19 cases rise
- IBM (IBM) Tops Q1 EPS by 14c, Revenue Beats
- Tesla's (TSLA) Musk says data logs from crashed vehicle show Autopilot was not enabled, car did not purchase FSD
- Oil hits $68 on Libya force majeure despite pandemic surge
- Oatly files for IPO; Plans to list on NASDAQ under the ticker 'OTLY' After 107% 2020 Revenue Growth
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coinbase (COIN) options to start trading April 20
- PetIQ, Inc. (PETQ) Gains on Barron's Pump
- Manchester United (MANU) Up 9% on Plans to Join a New European Super League, a New Competition Format Funded by JP Morgan
Create E-mail Alert Related CategoriesHot FDA News, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!